Researchers found that a combination of three drugs—dichloroacetate, metformin, and low-dose navitoclax—effectively targets both senescent (aging) and cancer cells. This tripartite approach works by depriving these unhealthy cells of the energy they need to survive while leaving healthy cells unharmed. In studies with older mice, this combination not only improved their physical performance on treadmills but also extended their lifespan by an impressive 41.7%.

For those interested in healthy aging, this discovery is significant. As we age, the risk of cancer increases, and the presence of senescent cells can contribute to various age-related diseases. The combination treatment demonstrated a potential to reduce the harmful effects of both senescence and cancer, suggesting that it could improve muscle strength, energy levels, and overall longevity in humans. The study showed that the triplet treatment killed about 60% of senescent cells while sparing healthy ones, which could lead to better health outcomes for older adults.

This research is still in the early stages, primarily conducted in mice, and while the results are promising, they are not yet proven in humans. The drugs used are already FDA-approved for other uses, which is a positive sign, but the combination has not undergone clinical trials in people. Therefore, while the findings are intriguing and could pave the way for future treatments, it’s important to remain cautious until more robust human studies are conducted.

For now, maintaining a healthy lifestyle, including regular exercise and a balanced diet, remains key. While the drug combination shows potential, it is essential to wait for further research before considering any changes to your health regimen.

Source: lifespan.io